30-Day Pharmacokinetic Evaluation of IV versus Subcutaneous Administration of Immunoglobulin with and without Recombinant Human Hyaluronidase in Dogs von Leesch, V.W, Johnson, B.A, Cook, C.S, Yocum, R.C, Schiff, R.I, Muchitsch, E.M, Teschner, W

Volltext

Recombinant Human Hyaluronidase Facilitates Dispersion of Subcutaneously Administered Gammagard Liquid and Enables Administration of a Full Monthly Dose in a Single Site to Patient... von Melamed, I.R, Stein, M.R, Wasserman, R.L, Leibl, H, Engl, W, Yocum, R.C, Schiff, R.I

Volltext